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ABSTRACT
OBJECTIVES: Re-mediastinoscopy could be risky because of adhesions from the previous mediastinoscopy. 
The aim of this study was to evaluate the effi cacy of a bio-resorbable barrier on adhesion formation in a re-
mediastinoscopy rat model.
METHODS: Mediastinal dissection similar to mediastinoscopy was done in twenty-eight rats and a polymeric 
fi lm comprising of polylactic acid and polyethylene glycol (Repel-cv®, SyntheMed Inc., NJ, USA) was placed 
on trachea in the study groups. Group 1 (sham, sacrifi ced at day 30), Group 2 (single barrier, sacrifi ced at day 
30), Group 3 (single barrier, sacrifi ced at day 60), Group 4(double layer barrier, sacrifi ced at day 60). Medias-
tinal adhesions, degree of infl ammation, vascular proliferation, foreign body reaction and fi broblast proliferation 
was compared.
RESULTS: Macroscopic dissection showed signifi cantly dense adhesions in Sham Group and Group 3 (p < 
0.05). Histopathologic examination showed that there was a signifi cant difference between groups when the 
foreign body reaction and fi broblast proliferation was evaluated (p<0.05). No signifi cant difference was present 
between the groups in terms of infl ammation and vascular proliferation (p>0.05).
CONCLUSIONS: This unique experimental study showed that adhesion barrier was effective as single layer 
application at day 30 and double layer application at day 60. At clinical conversion, by the application of barrier, 
the formation of adhesions might be decreased to provide a safe re-mediastinoscopy (Tab. 2, Fig. 4, Ref. 23).
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Introduction
Re-mediastinoscopy is one of the repeat surgical interventions 
in thoracic surgery. The current indications of re-mediastinoscopy 
are the negative result or incomplete fi rst mediastinoscopy, recur-
rent and second primary lung cancer, lung cancer occurring after 
a malignant disease, and restaging following induction therapy. 
The most frequent indication among them is restaging. The im-
portance of restaging is clearly stated because only patients with 
proven mediastinal downstaging will benefi t from a subsequent 
surgical resection (1–3).
The results of remediastinoscopy, however, may be disappoint-
ing because an incomplete or absent biopsies can be obtained due 
to fi brosis or adhesion formation in the previous mediastinoscopy 
(4). An insuffi cient staging up to 18 % of the patients, and 0.7 % 
morbidity due to severe hemorrhage was reported (5). Accord-
ingly, while some authors were considering re-mediastinoscopy 
as an invaluable tool for restaging after induction therapy, others 
defi ned new techniques to access the mediastinum (3, 6).
Currently, adhesion barriers were used in many surgical in-
terventions and had become of an increasing interest because of 
their effectiveness. Unfortunately, experimental studies to reduce 
the adhesions after mediastinoscopy are limited to a single study 
in rats concluding anti- adhesive agents could reduce the diffi cul-
ties during re-mediastinoscopy performed within a month (7). 
However, to the best of our knowledge, late results of a biore-
sorbable adhesion barriers to reduce mediastinal adhesions were 
not investigated.
Here we performed an experimental study to evaluate the ef-
fi cacy of a bioresorbable barrier on adhesion formation at fi rst and 
second month, and when it was used as single or double layer, in 
a re-mediastinoscopy rat model.
Materials and methods
Twenty-eight male Wistar albino rats (300–350 g, 4–6 months 
old) were used in this study. All animals received human care in 
compliance with the European Convention on Animal Care and 
the study protocol was approved by the Animal Ethics Committee 
of the University (Protocol number: 10/15). 
Repel-cvR (SyntheMed Inc.,NJ, USA) is a bioabsorbable adhe-
sion barrier, which reduces the severity of postoperative cardiac 
adhesions in pediatric patients. Its components are polylactic acid 
and polyethylene glycol. The polymers used in it have been used in 
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many medical implants and defi ned to be safe and biocompatible. 
The thickness is 137 microns. It does not require placement on a 
dry surgical area. The polymers degrade after exposure to moisture 
and are eliminated from the body in approximately one month.
Rats were divided into the four groups as; Group 1 (Medias-
tinal dissection, sacrifi ced at day 30, n = 7), Group 2 (Mediastinal 
dissection, single barrier applied group, sacrifi ced at day 30, n = 
7), Group 3 (Mediastinal dissection, single barrier applied group, 
sacrifi ced at day 60, n = 7), Group 4 (Mediastinal dissection and 
double layer barrier applied group, sacrifi ced at day 60, n = 7).
Surgery
Rats were anesthetized with 50 mg/kg ketamine hydrochloride 
plus 10 mg/kg xylazine hydrochloride administered intramuscu-
larly. Under sterile conditions, a mid-cervical horizontal skin in-
cision was made over the trachea. In the Group 1 (Sham group), 
upper mediastinal dissection was done, i.e. the strap muscles were 
divided and retracted laterally, by the use of a mosquito clamp the 
pretracheal region was prepared to access the paratracheal area 
and a dissection was extended to the subcarinal region. Gaze abra-
sion of the mediastinoscopy tract was performed and numerous 
bleedings were created, than they were tamponated by a sponge 
for hemostasis. In the Groups2 and 3 after a similar dissection, 
Repel-cvR was prepared in adequate size, soaked in saline solu-
tion for approximately two minutes and then placed and fi xed 
in the pocket that was created previously. In the Group 4 after 
mediastinal dissection and similar preparations, the barrier was 
bended and applied as double layer. The strap muscles and skin 
were closed sequentially. 
Autopsy
Autopsies were performed on day 30 in the Groups 1, 2 and on 
day 60 in the Groups 3 and 4 under a general anesthesia.
Macroscopy and microscopy
Trachea was totally removed without compromising strap 
muscle integrity and evaluated for adhesion formation.
Correctly oriented sections of the dissection site and nearby 
trachea were taken and placed in 10 % buffered formalin. After 
the tissues were embedded in paraffi n, slices of 4–6 microns were 
prepared and stained with Hematoxylin-Eosin. Masson Trichrome 
stain was also used to evaluate fi brosis.
Group 1
Sham
Group 2
30 days 1 layer
Group 3
60 days 1 layer
Group 4
60 days 2 layers
p
Macroscopic
Pretracheal adhesions 19.50 7.50 21.50 9.50 0.001a
Microscopic
Degree of infl ammation 16.64 19.36 13.79 8.21 0.056
Vascular proliferation 17.50 13.50 17.50 9.50 0.109
Foreign body reaction 16.00 16.00 8.00 18.00 0.013a
Fibroblast proliferation 20.50 7.50 22.50 7.50 0.000a
Data were given as the mean ranks. The differences among the groups considering all variables were evaluated by Kruskal-Wallis test. When the p value from Kruskal-Wallis 
test was statistically signifi cant, Mood median test was used to determine the group that caused the difference.
a The difference was signifi cant (p < 0.05)
Tab. 1. The scores of macroscopic and microscopic examination of groups.
Groups Mean St. Dev. St. Er. 95% C.I. for 
mean
Min Max
Macroscopic adhesion 1 2.00 0.816 0.309 1.24 2.76 1 3
2 0.29 0.488 0.184 -0.17 0.74 0 1
3 2.29 0.488 0.184 1.83 2.74 2 3
4 0.57 0.976 0.369 -0.33 1.47 0 2
Degree of infl ammation 1 1.86 1.464 0.553 0.50 3.21 0 3
2 2.29 0.756 0.286 1.59 2.98 1 3
3 1.57 0.535 0.202 1.08 2.07 1 2
4 0.71 0.951 0.360 -0.17 1.59 0 2
Vascular proliferation 1 0.71 0.488 0.184 0.26 1.17 0 1
2 0.43 0.535 0.202 -0.07 0.92 0 1
3 0.71 0.488 0.184 0.26 1.17 0 1
4 0.14 0.378 0.143 -0.21 0.49 0 1
Foreign body reaction 1 0.86 0.378 0.143 0.51 1.21 0 1
2 0.86 0.378 0.143 0.51 1.21 0 1
3 0.29 0.488 0.184 -0.17 0.74 0 1
4 1.00 0.000 0.000 1.00 1.00 1 1
Fibroblast proliferation 1 1.71 0.756 0.286 1.02 2.41 1 3
2 0.00 0.000 0.000 0.00 0.00 0 0
3 2.14 0.900 0.340 1.31 2.97 1 3
4 0.00 0.000 0.000 0.00 0.00 0 0
St. Dev. – Standard deviation, St. Er. – Standard error, C.I. – Confi dence interval, Min – minimum, Max – maximum
Tab. 2. Additional statistical analysis for macroscopic adhesion and histopathologic markers.
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Macroscopic and histopathologic analysis on different aspects 
was done by two pathologists who were blinded to the groups. 
Macroscopic adhesions were graded as: grade 0, null; grade 1, 
mild; grade 2, moderate and grade 3, severe. The degree of in-
fl ammation, vascular proliferation, foreign body reaction and fi -
broblasts were evaluated and scored. The degree of infl ammation 
was graded as: grade 0, null; grade 1, mild; grade 2, moderate and 
grade3, severe. If vascular proliferation was absent it’s graded as 
0, if present it’s graded as 1. If foreign body reaction was absent 
it’s graded as 0, if present it’s graded as 1. Fibroblast proliferation 
was graded as: grade 0, null; grade 1, mild; grade 2, moderate and 
grade 3, extensive (7).
Statistical analysis
Data analysis was performed by using the SPSS for Win-
dows, version 15.0 (SPSS Inc., Chicago, IL, United States) and 
MINITAB version 16. The differences among the groups consid-
ering all variables were evaluated by Kruskal–Wallis test. When 
the p value from Kruskal–Wallis test was statistically signifi cant, 
Mood median test was used to determine the group that caused 
the difference. The p value less than 0.05 was considered as sta-
tistically signifi cant.
Results
Starting from awakening period no problems were observed in 
any rats and none of them died. The scores of the macroscopic and 
microscopic examination is shown in Tables 1 and 2. During mac-
roscopic dissection, dense adhesions were observed in the Group1 
and 3 (Fig. 1).There was a signifi cant difference between the groups 
when macroscopic adhesions were evaluated (p < 0.001) and the 
adhesions were signifi cantly fewer in the Groups 2 and 4 (Fig. 2). 
There was no signifi cant difference between the groups when a 
degree of infl ammation and vascular proliferation were evaluated 
(p = 0.056, p = 0.109). Figure 3 shows the histopathologic sections 
of trachea and mediastinum. There was a signifi cant difference be-
tween the groups when foreign body reaction and fi broblasts were 
Fig. 1. Macroscopic appearance of paratracheal region (a) shows that anterior and lateral tracheal region is free of adhesions, (b) shows the 
dense adhesions at the same region in sham group.
A B
Fig. 2. Interval plot of macroscopy. In Groups 2 and 4, adhesions were 
signifi cantly less than other Groups.
Fig. 3. Microscopic section of trachea and mediastinum. a) Massive 
fi brosis at sham group where no barrier was used. Hematoxylin and 
Eosin, X 40. b) Minimal fi brosis formation around membrane at 30 
day scarifi cation and single layer barrier used group. Hematoxylin 
and Eosin, X 40. c) Massive fi brosis around membrane and chronic 
infl ammation at group 3 and collagen fi bers encircling foreign body 
granulomas. Masson Trichrome, X 40. d) Extensive degradation of 
double layered membrane around trachea. Hematoxylin and Eosin, 
X 40. TL – Tracheal lumen, F – Fibroblast, C – Cartilage, B – Bar-
rier, I – Infl ammation.
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evaluated (p = 0.013, p < 0.001). Foreign body reaction was sig-
nifi cantly lower in the Group 3 when compared to the other groups. 
Fibroblasts, which indicate adhesions, were lower in the Groups 
2 and 4 when compared to the Sham Group and Group 3 (Fig. 4).
Discussion
In lung cancer, the determination of nodal status is essential 
for planning therapy and assessing prognosis. For locally advanced 
lung cancer, re-mediastinoscopy is mainly indicated to evaluate 
the tumor response in mediastinal lymph nodes after an induction 
therapy and to indicate further therapy for a defi nitive pathologi-
cal proof to show a persistent node invasion i.e. N2 (8). However, 
mediastinal restaging after the induction therapy remains a diffi cult 
and controversial issue although it is technically possible (9–12).
Beginning from 1975, several re-mediastinoscopy series have 
been reported. Early mediastinoscopy and alternative routes were 
offered to overcome the adhesions between innominate artery and 
the trachea (6). It’s reported that if the fi rst mediastinoscopy was 
more complete, more adhesions and fi brosis developed and it was 
concluded that successful mediastinoscopies might result in a dis-
appointment during re-mediastinoscopy (12). As known, the most 
serious complication of a mediastinoscopy is major hemorrhage 
(0.4 %) where azygos vein, innominate, pulmonary and bronchial 
arteries were the most common injured vessels. Despite technical 
complexity, re-mediastinoscopy still remains as a valuable tool 
although it has a potentially morbidity (1.9 %) (13–15).
Unfortunately, after recurrent surgical interventions to the 
same anatomical area, optimal means to prevent adhesions are 
not available. For this purpose, different agents such as prosthetic 
barriers, xenograft materials, solutions containing pharmacologi-
cal agents, bioresorbable membranes, anti-infl ammatory drugs 
have been used. Among them bioresorbable membranes were the 
most preferred one as it provides a temporary mechanical barrier 
reducing or preventing the formation of adhesions during tissue 
repair (16–19).
In this experimental study, we used Repel-cv® as an adhesion 
barrier. It is a sterile and bioresorbable transparent fi lm comprising 
of polylactic acid (52 % LA) and polyethylene glycol (47 % EO). 
Its excellent use to reduce the formation of postoperative adhe-
sions between pericardium and sternum after cardiac surgery was 
reported, which directed us to use this barrier in our experimental 
study. In literature, the mechanism of action is stated as; during 
the separation of the opposing tissues from each other, it serves to 
reduce postoperative adhesion formation during the early phase 
of tissue repair and regeneration (16, 20).
Two experimental studies demonstrated the effi cacy Repel-
cv® in the prevention of retrosternal and pericardial adhesions 
at time of necropsy at 20 and 21 days (21, 22). In a single re-me-
diastinoscopy rat model by Solak et al (7) it was concluded that, 
although adhesions were present, anti-adhesive barriers could 
reduce the diffi culties met during re-mediastinoscopy that was 
performed within a month. However, the late results concerning 
the effi cacy of bioresorbable adhesion barriers to reduce medias-
tinal adhesions were not investigated. So we decided to test our 
hypothesis that, late effects of barriers had to be investigated in 
a model, because in clinical translation, the time period between 
fi rst and second mediastinoscopy might be postponed and it could 
exceed one month due to the ongoing chemotherapy.
The most important indicator of adhesion are fi broblasts, which 
were evaluated and compared between the groups. The results 
didn’t support the effi cacy of this bioresorbable adhesion barrier 
at the second month when used as a single layer, which was not 
mentioned in any report concerning a re-mediastinoscopy model. 
However, fortunately when a double layer of same barrier was 
used, it signifi cantly reduced the mediastinal adhesion formation 
at the second month similar to single layer used at fi rst month.
Different conclusions were done for the technical practica-
bility of re-mediastinoscopy but it was clear that early re-medi-
astinoscopy would be much easier. We think that this knowledge 
would direct further evaluation of the patients for restaging, when 
re-mediastinoscopy is considered. Although PET might be used in 
mediastinal restaging, due to its low sensitivity, it is not accepted 
to be an optimal technique. It was reported that infl ammatory reac-
tion occurring after chemoradiotherapy caused a strong accumula-
tion of FDG thus false positive result were seen as high as 20 %. 
Currently, to provide cytohistological information for mediastinal 
nodal involvement, minimally invasive staging procedures such as 
endobronchial or endoscopic esophageal ultrasound was offered 
for the initial intervention. Mediastinoscopy could be performed 
afterwards and reserved for restaging after induction therapy, and 
a more diffi cult remediastinoscopy could be defeated technically 
(3, 10, 23). Contrary to this suggestion in one of the largest series 
of the literature, Marra et al (15) pointed that remediastinoscopy 
could be done without mortality having a higher sensitivity, speci-
fi city and accuracy compared to radiologic investigations, PET/
CT and EBUS/EUS.
Notably, this unique and encouraging experimental study 
showed that murine models rather than large animals could be 
used in re-mediastinoscopy studies for further investigations. 
We think that, the dissection and placement of barrier would be 
easier and less time consuming in rat models. Another advantage 
of small animal was that gross pathological analysis could be 
done concerning the whole trachea and surrounding tissues on 
the same section.
Fig. 4. Interval plot of fi brosis. In Groups 2 and 4,fi broblast prolifera-
tion indicating adhesions were signifi cantly less than other Groups.
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As a conclusion, the bioabsorbable membrane composed of 
polylactic acid and polyethylene glycol used after the initial me-
diastinoscopy could reduce the diffi culties during re-mediastinos-
copy, which was performed within a month, and late results were 
also satisfactory when double layer was used.
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